Literature DB >> 20018549

Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease.

Jee-Young Lee1, Jong-Min Kim, Jae Woo Kim, Jinwhan Cho, Won Yong Lee, Han-Joon Kim, Beom S Jeon.   

Abstract

OBJECTIVES: To survey the point prevalence of impulse control and repetitive behavior disorders (ICRBs) in patients with Parkinson disease (PD) and to determine the relationship between PD medication dose and the risk of ICRBs.
METHODS: A multicenter cross-sectional survey was applied to consecutive patients with PD over a 3-month period. The presence of ICRBs was screened using a modified version of the Minnesota Impulsive Disorders Interview that comprised five ICRB modules: compulsive buying, gambling, sexual behavior, eating, and punding. Data regarding the patients' clinical features and concurrent anti-PD drugs were also collected during the interview. Adjusted odds ratios (ORs) of the daily doses of dopamine agonist and L-dopa for the development of an ICRB were calculated after adjustment for clinical variables.
RESULTS: Among the 1167 patients recruited, 118 (10.1%) exhibited ICRBs. Punding was the most common ICRB (4.2%), followed by compulsive eating (3.4%), sexual behaviors (2.8%), buying (2.5%), and gambling (1.3%). Two or more ICRBs were present concomitantly in 34 of these 118 patients (28.8%). There were dose-response relationships between the dopamine agonist dose and the ORs for compulsive buying, gambling and sexual behaviors. On the other hand, the OR for punding was positively correlated with the dose of L-dopa. The OR for compulsive eating was not associated with the dose of dopamine agonist or L-dopa.
CONCLUSIONS: The dose of dopaminergic medication is significantly associated with the development of ICRB, except compulsive eating, in PD. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018549     DOI: 10.1016/j.parkreldis.2009.12.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  36 in total

Review 1.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

2.  Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations.

Authors:  Hee Jin Kim; Han-Joon Kim; Jee-Young Lee; Ji Young Yun; So Yeon Kim; Sung Sup Park; Beom S Jeon
Journal:  J Neurol       Date:  2011-05-29       Impact factor: 4.849

Review 3.  New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease.

Authors:  Giacomo Grassi; Giovanni Albani; Federica Terenzi; Lorenzo Razzolini; Silvia Ramat
Journal:  Neurol Sci       Date:  2021-04-14       Impact factor: 3.307

Review 4.  Pathological gambling: prevalence, diagnosis, comorbidity, and intervention in Germany.

Authors:  Beate Erbas; Ursula G Buchner
Journal:  Dtsch Arztebl Int       Date:  2012-03-09       Impact factor: 5.594

Review 5.  Sleep in Parkinson's Disease with Impulse Control Disorder.

Authors:  Michela Figorilli; Patrizia Congiu; Rosa Lecca; Gioia Gioi; Roberto Frau; Monica Puligheddu
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-11       Impact factor: 5.081

Review 6.  Impulse control disorders in Parkinson's disease.

Authors:  Ana Marques; Franck Durif; Pierre-Olivier Fernagut
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

7.  Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease.

Authors:  Juyeon Kim; Mijin Kim; Do Young Kwon; Woo-Keun Seo; Ji Hyun Kim; Jong Sam Baik; Seong-Beom Koh
Journal:  J Neurol       Date:  2012-08-15       Impact factor: 4.849

8.  Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors.

Authors:  Charlotte R Housden; Sean S O'Sullivan; Eileen M Joyce; Andrew J Lees; Jonathan P Roiser
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

Review 9.  Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease.

Authors:  Nandakumar S Narayanan; Robert L Rodnitzky; Ergun Y Uc
Journal:  Rev Neurosci       Date:  2013       Impact factor: 4.353

Review 10.  Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Authors:  Emke Maréchal; Benjamin Denoiseux; Ellen Thys; David Crosiers; Barbara Pickut; Patrick Cras
Journal:  J Neurol       Date:  2014-05-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.